A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Clinical trial NCT06049030 · UNKNOWN

Trial details

NCT number: NCT06049030
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2023-09-25
Primary completion: 2024-09-25
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.